Background: To examine how surgical robot emergence affects prostate-cancer patient behavior in seeking radical prostatectomy focusing on geographical accessibility. Methods: In Japan, robotic surgery was approved in April 2012. Based on data in the Japanese Diagnosis Procedure Combination database between April 2012 and March 2014, distance to nearest surgical robot and interval days to radical prostatectomy (divided by mean interval in 2011: % interval days to radical prostatectomy) were calculated for individual radical prostatectomy cases at non-robotic hospitals. Caseload changes regarding distance to nearest surgical robot and robot introduction were investigated. Change in % interval days to radical prostatectomy was evaluated by multivariate analysis including distance to nearest surgical robot, age, comorbidity, hospital volume, operation type, hospital academic status, bed volume and temporal progress. Results: % Interval days to radical prostatectomy became wider for distance to nearest surgical robot <30 km. When a surgical robot emerged within 30 and 10 km, the prostatectomy caseload in non-robot hospitals reduced by 13 and 18% within 6 months, respectively, while the robot hospitals gained +101% caseload (P < 0.01 for all) Multivariate analyses including 9759 open and 5052 non-robotic minimally invasive radical prostatectomies in 483 non-robot hospitals revealed a significant inverse association between distance to nearest surgical robot and % interval days to radical prostatectomy (B = −17.3% for distance to nearest surgical robot ≥30 km and −11.7% for 10-30 km versus distance to nearest surgical robot <10 km), while younger age, high-volume hospital, open-prostatectomy provider and temporal progress were other significant factors related to % interval days to radical prostatectomy widening (P < 0.05 for all). Conclusions: Robotic surgery accessibility within 30 km would make patients less likely select conventional surgery. The nearer a robot was, the faster the caseload reduction was.
Introduction
Prostate cancer is the most common type of cancer among males in Japan, and its management is a large global public health issue (1) . Traditionally, open radical prostatectomy was widely recognized as the reference standard for treatment of localized prostate cancer. However, since the recent emergence of surgical robotic technology in clinical settings, robot-assisted radical prostatectomy (RARP) has become the popular surgical method of choice among urologists in many developed nations (2) (3) (4) .
In Japan, the national universal healthcare insurance began covering RARP in April 2012 as a fourth radical prostatectomy procedure, belatedly following laparoscopic radical prostatectomy in 2006 and minimal-incision endoscopic radical prostatectomy (gasless single-port-access endoscopic surgery) in 2008 (4) . Despite being a latecomer, the number of robotic surgeries increased rapidly after its approval. As of the end of 2015, Japan possessed more than 200 surgical robot systems, representing the second largest number worldwide (5) .
While the rapid and explosive spread of this new technology would strongly change patient behavior in the selection of radical prostatectomy procedures, detailed analyses on the relationship between diffusion of innovation and patient behavior are very limited (2) .
We hypothesized that geographical accessibility to a surgical robot would be an important factor for patients with prostate cancer to select RARP or other non-robotic radical prostatectomy procedures. Concretely, among hospitals possessing a surgical robot (robot hospitals), the robot introduction would positively influence new prostatectomy patient acquisition. Meanwhile, hospitals without a surgical robot (non-robot hospitals) would find it harder to obtain new radical-prostatectomy patients when a robot hospital emerged in their neighborhood, and the interval days to radical prostatectomy (IDRP) would become wider and wider.
In the present study, the above hypotheses were examined using a Japan-wide population-based clinical database.
Materials and methods

Case selection
Patient data for the present study were obtained from the Diagnosis Procedure Combination (DPC) database, a Japan-wide inpatient administrative claims database. In 2014, the database had about 1000 participating hospitals, representing~50% of acute-care hospitalizations throughout Japan (3, 4) .
The patients selected for the present study were those diagnosed with malignant neoplasm of the prostate (code C61 in the International Classification of Diseases and Related Health Problems 10th Revision) who underwent open, laparoscopic, minimal-incision endoscopic or RARP (Japanese surgical codes K843, K843-2, K843-3 and K939-4, respectively) from April 2012 to March 2014.
Ethics
Because the data in the DPC database were thoroughly de-identified and the present study was designed as a secondary analysis of administrative claims data, informed consent was not required. The study design conformed the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013). The institutional review board and ethics committee of The University of Tokyo approved the study.
Distance to surgical robot and IDRP
In each patient undergoing radical prostatectomy at a non-robotic hospital, distance to nearest surgical robot (DSR, km) and IDRP were calculated as follows. DSR was defined as the geodesic distance calculated by the Hubeny Formula from the non-robotic hospital to the nearest robot hospital (6) . IDRP was defined as the interval days between the current and last radical prostatectomy in the hospital. For example, when the current prostatectomy was performed on April 10 and the previous prostatectomy was performed on April 3, IDRP was 7 days. In general, a narrow IDRP reflects high attractiveness of radical prostatectomy patients to the institution, and IDRP becomes wider according to decreasing radical prostatectomy caseload. A derived standardized value of IDRP, %IDRP, was defined as IDRP divided by the mean IDRP of the hospital in the financial year of 2011 (April 2011 to March 2012; just before the Japanese universal healthcare insurance started to cover RARP).
Statistical analysis
First, among robot hospitals, the caseloads of radical prostatectomy before and after robot introduction were examined. Meanwhile, among non-robot hospitals, the caseloads of radical prostatectomy before and after the day for DSR ≤ 30 km and DSR ≤ 10 km were confirmed. The changes were assessed by a paired t-test.
Second, among non-robot hospitals, the relationship between DSR and %IDRP was depicted using a method for restricted cubic spline curves, a useful tool that allows flexible descriptions of nonlinear relationships among variables (7, 8) .
Finally, multivariate linear regression analyses were performed for %IDRP with covariates of DSR, age, comorbidities at admission, oncological stage (according to the International Union Against Cancer) (9), surgical type of prostatectomy, temporal progress, hospital academic status (academic or non-academic), and hospital volume (annual caseload of radical prostatectomy at each hospital). Comorbidities were converted to a linear score of the Charlson comorbidity index (CCI) based on the rule of Quan et al. (10) . The hospital clustering effect was adjusted by a general equation estimation method (11) .
All statistical analyses were conducted using SPSS version 22.0 (IBM SPSS, Armonk, NY, USA) and R version 3.0.2 software (R Foundation for Statistical Computing, Vienna, Austria) with the RMS 4.0-0 package (12, 13) . For univariate comparisons, the χ 2 test
and Mann-Whitney U-test were adopted as appropriate. The threshold for significance was P < 0.05.
Results
Complete data for radical prostatectomy caseloads 3 months before and 6 months after the day for DSR < 30 km, DSR < 10 km, and robot introduction were available for 389, 264, and 75 hospitals, respectively. Mean changes in prostatectomy caseloads before and after the day for (i) DSR < 30 km, (ii) DSR < 10 km and (iii) robot introduction was shown in Fig. 1 . When the surgical robot appeared within 30 km from a non-robot hospital, the prostatectomy caseload slightly declined by 13% after 6 months (paired t-test, P = 0.019). The decline accelerated when DSR was <10 km, with 18% reduction after 6 months (P = 0.001). Meanwhile, the hospital introducing the surgical robot increased their prostatectomy caseload by 88% after 3 months and 101% after 6 months (P < 0.001 for both).
Both DSR and %IDRP were available for 9759 open, 3642 laparoscopic and 1410 minimal-incision endoscopic cases in 483 nonrobot hospitals. Table 1 presents the details of the patient baseline characteristics classified by DSR. Significant background variation was observed. In particular, higher %IDRP was noted according to shorter DSR (P < 0.001).
The detailed relationship between DSR and %IDRP was depicted by a restricted cubic spline curve, as shown in Fig. 2 . Because a wide %IDRP represented a low ability to acquire new radical prostatectomy cases, the graph indicated that the nearer a surgical robot was to a non-robot hospital, the less likely patients were to gather at the non-robot hospital. The %IDRP became wider from the point of DSR = 30 km and the increase accelerated for DSR < 10 km. Table 2 shows the results of the multivariate regression analyses for %IDRP among non-robot hospitals. After adjustment for background characteristics, a significant inverse association was observed between DSR and %IDRP (B = −17.3% for DSR ≥ 30 km and −11.7% for DSR 10-30 km versus DSR < 10 km, P < 0.05 for both), while younger age, high-volume hospital, open-prostatectomy provider and temporal progress were other significant factors related to %IDRP widening. Comorbidity, institutional academic status and bed volume were not associated with change in %IDRP.
Discussion
This study is the first to document the way in which the emergence of new surgical robot technology impacts on the surgical caseload of non-robot hospitals and to analyze how innovative technology affects patient behavior in seeking the innovative treatment. Our results showed that by introducing a surgical robot, the prostatectomy caseload increased by 101% within 6 months, while nonrobot hospitals had caseload decreases of about 13 and 18% when a robot hospital emerged within 30 and 10 km, respectively. According to the data shown in Fig. 2 , patient behavior in seeking a new innovative treatment would depend on geographical accessibility, and a distance of ≤30 km could be an initial trigger point. In addition, the multivariate analyses suggested that younger patient age, high-volume hospital, traditional open-prostatectomy provider and temporal progress would be factors for a non-robot hospital appearing less attractive to patients with prostate cancer. The power of a surgical robot to draw patients has been documented in several papers. In the United States, more than 70% of prostatectomies were performed by a surgical robot as of 2011, and strong centralization effects of surgical robots in the United States were reported (3). Another paper documented that between 2000 and 2008, the number of prostatectomies increased by 74% even though the number of hospitals performing prostatectomies decreased by 19%, and this large caseload increase was almost completely explained by hospitals in the top caseload quartile investing in robotic technology (14) (15) (16) . A report from Germany, wherein the number of prostatectomies reduced by 23% from 2006 to 2013, also mentioned that the presence of a robotic system was the most important aspect for retaining a high-volume center (17) . Based on our analysis of Japanese cases, RARP gained in popularity quickly and non-robot high-volume centers (≥40 cases/year) lost their prostatectomy patients most widely. Therefore, centralization from nonrobot hospital to robot hospital is steadily progressing in Japan, as in other parts of the world.
Another unique finding of the present study was that a surgical robot had the ability to attract patients in the range of~30 km. This area size of 30 km is similar to the market area of a super-regional shopping center (8-40 km), such as large-scale luxury department stores that mainly sell expensive products (18) . As one rationalized explanation for the similarity, it is probably safe to acknowledge that RARP is a luxury medical procedure, in the sense that a surgical robot is not essential for urologists to perform radical prostatectomy. In other words, urologists are able to perform the surgery using traditional alternative surgical skills such as open and laparoscopic approaches instead of a surgical robot.
This study provides an answer to the question of how innovational therapeutic technology spreads among patients. The influence ranged within~30 km, and the nearer the robot was, the stronger the influence was. Meanwhile, some caution is required to generalize the result for a 30-km range of robot influence, because this could vary on a country-to-country basis. For instance, in the United States, one-third of RARP patients were estimated to travel >40 km to receive RARP in 2011 (19) . Advanced centralization of RARP and the vast extent of the United States would be two reasons for such long traveling distances. Further investigations are required to reveal patient behavior in seeking out new treatments.
In the multivariate analyses, robot-oriented preference was observed for young age, high-volume center and traditional opensurgery provider. According to the Law of Diffusion of Innovation, young people are more likely to accept a new product than the elderly (2, 20) . Their strong desire to preserve erectile function could be another reason for selecting RARP, because of the known robotic superiority in this regard (21) . Patients leaning toward visiting highvolume centers for radical prostatectomy would be likely to hold We would like to provide an explanation for why the change in prostatectomy frequency was analyzed based on the prostatectomy interval, instead of the caseload for a certain period, in the present study. This was because a difference on a one-day-change basis is generally finer than a difference on a one-case-change basis. For example, in a situation with three cases per 30 days (interval of 10 days), the minimum detectable difference on an interval basis would be about 10% (one day change from 10 days), while that on a caseload basis would be higher at~33% (one case change from three cases).
A difference related to urban and rural areas is another interesting issue. According to an additional analysis involving urban attribution, no significant difference in %IDRP was observed by urban or rural location (data not shown).
Some limitations to the present study should be acknowledged. First, because of the nature of a retrospective database study, unobserved confounders could bias the results. Second, DSR was simply measured as the direct geographical distance. Altitudes, detours and moving methods such as walking, cars, or trains were not taken into consideration. However, regarding hospital-tohospital distance in the present study, the issue of how to move between two hospitals was not very important, because the patients did not actually move from one hospital to another hospital. Third, data on non-surgical therapeutic options, including radiation therapy or active surveillance, were not included in the study because of the database design. Thus, our results cannot be applied to patients who selected non-surgical treatment. Fourth, an administrative claims database might contain some inadequate coding, which could lead to underestimation or overestimation of events. Fifth, because clinical settings vary largely from one country to another, the generalizability of our results could be limited. Finally, this study did not include RARP cases without national healthcare insurance, because these comprised a small group and were not registered in the database.
Despite these limitations, the present investigation provides new insights in patient behavior changes in terms of a newly emerging surgical robot during the first 2 years after the initial introduction of this technology in Japan, which are quite worthwhile for other robotic surgeries and new technologies.
In conclusion, a surgical robot influenced patient behavior in seeking radical prostatectomy within the range of 30 km. Robot accessibility within 30 km would make patients less likely select conventional open or non-robotic minimally invasive surgery. The nearer a robot was, the faster the reduction in caseload was.
